OBI Pharma Invited to Host Workshop at World ADC London
Sharing ADC Development Insights and Unveiling Linker Technology Details for the First Time

OBI Pharma (4174.TWO) was invited by the meeting organizer to present two talks, participate in a Plenary Panel, and host a workshop. At the 15th Annual World ADC London 2025, OBI Pharma will showcase its innovative research achievements in the field of Antibody-Drug Conjugates (ADC). As the largest ADC-focused event in Europe, the conference, held in London from 3/3 to 3/6, gathered over 1000 industry experts and featured 110 speakers from academia and industry. The event centered on advancing drug design, optimizing clinical performance, accelerating manufacturing processes, and expanding ADC applications to benefit more patients.